The clinical trial of TSO, Trichuris suis ova or CNDO-201, will be a randomized, double-blind, placebo-controlled, multicenter study involving 250 Chrohn’s disease patents.
More Articles on Gastroenterology:
14 Top Symptoms Leading to Gastroenterology Outpatient Visits
Dr. Carol-Lee Collins Joins KRMC in Arizona
La Peer Health Systems Launches Barrett’s Esophagus Center of Excellence
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.